Prescription drug · ANDA
Terazosin Hydrochloride NDC 71610-854
Terazosin hydrochloride 1 mg/1 · Capsule · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71610-854-30 | 71610085430 | 30 CAPSULE in 1 BOTTLE (71610-854-30)Marketed from Sep 3, 2024 | |
| 71610-854-53 | 71610085453 | 60 CAPSULE in 1 BOTTLE (71610-854-53)Marketed from Sep 3, 2024 | |
| 71610-854-60 | 71610085460 | 90 CAPSULE in 1 BOTTLE (71610-854-60)Marketed from Sep 3, 2024 | |
| 71610-854-80 | 71610085480 | 180 CAPSULE in 1 BOTTLE (71610-854-80)Marketed from Sep 3, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Terazosin Hydrochloride
- Generic name (nonproprietary)
- terazosin hydrochloride
- Active ingredients
- Terazosin hydrochloride — 1 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074823
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 71610-854_214d9180-c434-330d-e063-6394a90a795cSPL ID 214d9180-c434-330d-e063-6394a90a795cSPL set ID 214d9b06-8d23-3ee8-e063-6394a90a1521RxCUI 313215UNII D32S14F082
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471610085430followed by a unit qualifier and the quantityPackage 71610-0854-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Terazosin capsules, USP are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules, USP. The long-term effects of terazosin capsules, USP on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined. Terazosin capsules, USP are also indicated for the treatment of hypertension. Terazosin capsules, USP can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 074823
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Amerisyn LLC | 87564-081 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-007 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-006 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-008 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-009 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-594 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-595 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Amerisyn LLC | 87564-082 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Amerisyn LLC | 87564-083 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Amerisyn LLC | 87564-084 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-001 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-201 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-004 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-202 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-002 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-203 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-003 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Amici Pharma, Inc. | 69292-204 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-698 |
- openFDA data updated
Med-Code stores this record for up to 24 hours before requesting it again.
Reference information only. Verify codes and billing rules against the applicable payer and official source before submitting a claim. How Med-Code handles data.